Drug intelligence / Profile preview

PTLS-001

Development stage
Preclinical
Lead developer
Primetime
Modality
Small Molecules
Administration
Parenteral
01

Overview

PTLS-001 (also known as PLS5) is a preclinical-stage small molecule mutual prodrug (Metual®) consisting of the chemotherapeutic agent paclitaxel covalently linked to the antidiabetic drug metformin. Developed by Primetime Life Sciences, PTLS-001 is designed to treat ovarian cancer by simultaneously delivering both active agents to the tumor site. Upon cleavage, paclitaxel acts as a microtubule stabilizer to inhibit cell division, while metformin targets mitochondrial complex I and PEN2 to activate AMPK, potentially overcoming chemoresistance and synergistically inhibiting tumor growth.

Other names
Metformin-paclitaxel mutual prodrugMetual prodrug of paclitaxel and metforminmetformin + paclitaxel mutual prodrug
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)ND1 (Mitochondrial electron transport chain complex I)TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on PTLS-001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PTLS-001.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call